1.Study on tissue distribution and pharmacokinetics of moxifloxacin in the urogenital system by orally administration with single dose in rats
Chongqing Medicine 2015;(32):4474-4477
Objective To explore the pharmacokinetics and tissue distribution in rats with a single dose by orally administra‐tion of moxifloxacin .Methods Totally 60 rats were equally divided into 10 groups with orally administration moxifloxacin for 50 mg/kg .The lungs ,uterus ,ovaries (tube) ,kidney ,ureter and bladder tissues were collected at different time points (before give med‐icine and after 0 .25 ,0 .50 ,1 .00 ,2 .00 ,3 .00 ,4 .00 ,6 .00 ,8 .00 ,12 .00 ,24 .00 h) .The concentrations of moxifloxacin in tissues were determined by the established HPLC method and the pharmacokinetic parameters were calculated by 3p97 .Results The established HPLC methods had good specificities ,and the linear range was between 0 .001 6-50 .000 0μg/mL for tissue sample .T1/2βof moxi‐floxacin were (13 .65 ± 3 .56) ,(12 .64 ± 2 .86) ,(13 .27 ± 3 .51) ,(13 .47 ± 3 .29) ,(14 .78 ± 2 .64) ,(11 .56 ± 1 .58)h in lung ,uterus , ureterine adnexa ,kidney ,ureter and bladder ;Cmax of moxifloxac in various tissues were (15 .61 ± 3 .58) ,(12 .48 ± 4 .57) ,(16 .18 ± 4 .21) ,(12 .65 ± 3 .17) ,(26 .68 ± 7 .42) ,(1 .13 ± 0 .58)μg/mL ;Tmax of moxifloxac in above tissues were (3 .15 ± 1 .24) ,(2 .66 ± 1 .74) ,(2 .97 ± 1 .65) ,(2 .58 ± 1 .36) ,(3 .47 ± 1 .84) ,(2 .46 ± 1 .87)h;AUC0 -t of moxifloxac in above tissues were (87 .2 ± 5 .41) , (70 .89 ± 4 .56) ,(92 .41 ± 7 .65) ,(88 .26 ± 6 .94) ,(170 .59 ± 21 .48) ,(14 .57 ± 5 .47)μg · h-1 · mL -1 .Conclusion Moxifloxacin had a higher concentration in ureterine adnexa and ureter by orally administration with single dose ,and it can maintain for a long time .
2.NINE STRAINS OF SERRATIA MARCESCENS ISOLATED FROM CLINICAL SAMPLES
Naixin ZHAO ; Kejing CHENG ; Shulian ZHAO ;
Microbiology 1992;0(05):-
Nine strains of Serratia rnarcescens were isolated from clinical samples. In the identification, 20 items of biochemical reactions and 124 items of substrate utilization tests have been used. Two strains, which have not been appointed to a biotype of the species, can utilize 3-hydroxybenzoate, 4-hydroxybenzoate or protoeatechuate as sole carbon source for growth. The growth in protocatechuate medium was more rapid as compared with 3 or 4-hydroxybenzoate medium. So, we here suggest that protocatechuate should be included in the substrate utilization for the genus. The other seven strains have been identified as Grimont' s A_2 subphenon of S. marcescens. Pencillin and other wall-acting antibiotics are all resisted by these strains; aminoglycoside antibiotics are almost all effective. Co-trimoxazole and sulfadiazine, though couldn't inhibite the growth of the strains, do inhibite their pigment production.